{"nct_id":"NCT01047579","title":"A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease","status":"COMPLETED","status_verified_date":"2012-05","start_date":"2010-04","start_date_type":null,"primary_completion_date":"2012-01","primary_completion_date_type":"ACTUAL","completion_date":"2012-01","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}